Pro Share Advisors LLC Blueprint Medicines Corp Transaction History

Pro Share Advisors LLC

  • $48.7 Billion
  • Q2 2025

A detailed history of Pro Share Advisors LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Pro Share Advisors LLC holds 17,873 shares of BPMC stock, worth $2.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,873
Previous 16,650 7.35%
Holding current value
$2.31 Million
Previous $1.47 Million 55.47%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025
BUY
$79.22 - $128.4 $96,886 - $157,033
1,223 Added 7.35%
17,873 $2.29 Million
Q1 2025

May 08, 2025
SELL
$86.69 - $115.63 $369,732 - $493,161
-4,265 Reduced 20.39%
16,650 $1.47 Million
Q4 2024

Feb 13, 2025
BUY
$82.48 - $101.39 $436,319 - $536,353
5,290 Added 33.86%
20,915 $1.82 Million
Q3 2024

Nov 13, 2024
BUY
$84.1 - $120.5 $303,853 - $435,366
3,613 Added 30.08%
15,625 $1.44 Million
Q2 2024

Aug 13, 2024
SELL
$85.18 - $108.78 $273,087 - $348,748
-3,206 Reduced 21.07%
12,012 $1.29 Million
Q1 2024

May 08, 2024
BUY
$73.17 - $99.79 $92,779 - $126,533
1,268 Added 9.09%
15,218 $1.44 Million
Q4 2023

Feb 14, 2024
BUY
$43.96 - $92.84 $91,656 - $193,571
2,085 Added 17.57%
13,950 $1.29 Million
Q3 2023

Nov 13, 2023
BUY
$46.9 - $66.0 $2,063 - $2,904
44 Added 0.37%
11,865 $595,000
Q2 2023

Aug 10, 2023
BUY
$42.2 - $66.37 $26,543 - $41,746
629 Added 5.62%
11,821 $747,000
Q1 2023

May 11, 2023
SELL
$37.97 - $50.0 $89,305 - $117,600
-2,352 Reduced 17.37%
11,192 $503,000
Q4 2022

Feb 02, 2023
BUY
$41.06 - $66.48 $40,649 - $65,815
990 Added 7.89%
13,544 $593,000
Q3 2022

Nov 04, 2022
BUY
$49.93 - $77.7 $11,184 - $17,404
224 Added 1.82%
12,554 $828,000
Q2 2022

Aug 01, 2022
SELL
$45.23 - $70.15 $276,898 - $429,458
-6,122 Reduced 33.18%
12,330 $622,000
Q1 2022

May 10, 2022
SELL
$54.1 - $110.08 $221,214 - $450,117
-4,089 Reduced 18.14%
18,452 $1.18 Million
Q4 2021

Feb 08, 2022
BUY
$94.25 - $115.99 $107,727 - $132,576
1,143 Added 5.34%
22,541 $2.42 Million
Q3 2021

Nov 12, 2021
SELL
$80.98 - $109.47 $516,166 - $697,761
-6,374 Reduced 22.95%
21,398 $2.2 Million
Q2 2021

Aug 13, 2021
BUY
$82.78 - $101.0 $321,434 - $392,183
3,883 Added 16.25%
27,772 $2.44 Million
Q1 2021

May 14, 2021
BUY
$90.71 - $108.28 $183,959 - $219,591
2,028 Added 9.28%
23,889 $2.32 Million
Q4 2020

Feb 09, 2021
BUY
$92.08 - $124.48 $480,289 - $649,287
5,216 Added 31.34%
21,861 $2.45 Million
Q3 2020

Nov 13, 2020
SELL
$66.45 - $92.7 $17,476 - $24,380
-263 Reduced 1.56%
16,645 $1.54 Million
Q2 2020

Aug 03, 2020
BUY
$57.09 - $79.27 $349,676 - $485,528
6,125 Added 56.8%
16,908 $1.32 Million
Q1 2020

May 15, 2020
SELL
$48.11 - $82.22 $368,233 - $629,311
-7,654 Reduced 41.51%
10,783 $631,000
Q4 2019

Feb 12, 2020
SELL
$66.73 - $82.59 $105,233 - $130,244
-1,577 Reduced 7.88%
18,437 $1.48 Million
Q3 2019

Nov 12, 2019
BUY
$72.9 - $101.41 $70,931 - $98,671
973 Added 5.11%
20,014 $1.47 Million
Q2 2019

Aug 13, 2019
SELL
$73.54 - $97.8 $32,063 - $42,640
-436 Reduced 2.24%
19,041 $1.8 Million
Q1 2019

May 15, 2019
BUY
$48.7 - $86.6 $11,006 - $19,571
226 Added 1.17%
19,477 $1.56 Million
Q4 2018

Feb 14, 2019
SELL
$45.57 - $74.26 $168,791 - $275,059
-3,704 Reduced 16.14%
19,251 $1.04 Million
Q3 2018

Nov 14, 2018
SELL
$58.91 - $78.32 $53,961 - $71,741
-916 Reduced 3.84%
22,955 $1.79 Million
Q2 2018

Aug 13, 2018
SELL
$60.96 - $101.18 $108,021 - $179,290
-1,772 Reduced 6.91%
23,871 $1.52 Million
Q1 2018

May 14, 2018
SELL
$73.28 - $102.95 $131,317 - $184,486
-1,792 Reduced 6.53%
25,643 $2.35 Million
Q4 2017

Feb 14, 2018
BUY
$62.91 - $88.32 $171,807 - $241,201
2,731 Added 11.05%
27,435 $2.07 Million
Q3 2017

Nov 13, 2017
BUY
$42.37 - $69.67 $52,708 - $86,669
1,244 Added 5.3%
24,704 $1.72 Million
Q2 2017

Aug 11, 2017
BUY
N/A
23,460
23,460 $1.19 Million

Others Institutions Holding BPMC

# of Institutions
389
Shares Held
66.9M
Call Options Held
973K
Put Options Held
1.54M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $7.73B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email